Fact CheckerSign in

NCT05995665Completed

Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

This proposed research aims to assess the efficacy and feasibility of the EsoGLOVE in the inpatient rehabilitation setting. 1. Understanding the ability of the EsoGLOVE in providing exercise and assisting stroke patients with completing hand functional tasks, eventually improves patients' motor function and neural recovery.2. To generate evidence on this innovative device and further deploy it in clinical practice. A Health Technology Assessment (HTA) will be generated from this study to evaluate the cost-effectiveness of the intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
61 (actual)
First submitted
9 Aug 2023
Start date
11 Jul 2023
Primary completion date
31 Aug 2025
Lead sponsor
Alexandra Hospital
Diseases
Stroke
NCT number
NCT05995665

What you commit to

  • Study type: Interventional
  • Participants enrolled: 61
  • From 11 Jul 2023 to the primary completion date, 31 Aug 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recurrent stroke
  • Unstable medical conditions (e.g. heart attack, unstable blood pressure, infection, and etc.) or anticipated life expectancy of \<1 year.
  • Significant cognitive and communicative impairment (e.g. severe receptive aphasia, inattention, learning difficulty, and etc).
  • History of severe depression or active psychiatric disorder.
  • Severe spasticity (Modified Ashworth scale \>3) of the affected distal muscles, joint contractures or deformity, poor skin conditions (e.g. irritated skin, open wounds), amputation of fingers, and allergic condition (e.g. patients with allergies to adhesive gel).

Other

  • Poor trunk control or postural hypotension.

Who the study is looking for

  • Aged 21-90 years regardless of lesion size, race
  • Stroke type: ischemic or haemorrhagic
  • Medically stable conditions
  • Fugl-Meyer Assessment (FMA) of upper extremity impairment from 8-47 out of 66, or FMA of upper extremity impairment from 48-56 out of 66 if hand and wrist subscale is not full score and may still potentially benefit from study programme.
  • Able to give own consent, comprehend and follow commands
  • Able to sit upright and maintain sitting balance for at least 45 minutes
  • Able to stay alert and focus on the tasks at least 45 minutes and more.
  • Unilateral upper limb impairment

Age in the registry: 21 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alexandra Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
Jurong Community Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.